1. Application of novel dual wave meal bolus and its impact on glycated hemoglobin A1c level in children with type 1 diabetes.
- Author
-
Pańkowska E, Szypowska A, Lipka M, Szpotańska M, Błazik M, and Groele L
- Subjects
- Adolescent, Blood Glucose metabolism, Body Weight physiology, Child, Child, Preschool, Cross-Sectional Studies, Diabetes Mellitus, Type 1 blood, Dietary Carbohydrates administration & dosage, Dietary Carbohydrates analysis, Dietary Fats administration & dosage, Dietary Fats analysis, Dietary Proteins administration & dosage, Dietary Proteins analysis, Drug Dosage Calculations, Eating physiology, Female, Glycated Hemoglobin analysis, Humans, Hypoglycemic Agents therapeutic use, Infant, Infant, Newborn, Infusion Pumps, Implantable, Insulin analogs & derivatives, Insulin therapeutic use, Insulin, Long-Acting, Male, Patient Compliance, Treatment Outcome, Diabetes Mellitus, Type 1 drug therapy, Glycated Hemoglobin metabolism, Hypoglycemic Agents administration & dosage, Insulin administration & dosage, Insulin Infusion Systems
- Abstract
Background: An insulin pump is an advanced technology offering new options of bolus - normal (N), dual wave (D-W) or square wave (S-W) bolus to deliver mealtime insulin., Objectives: To assess the impact of D-W/S-W boluses on metabolic control (glycated haemoglobin A1c, HbA1c) and to estimate the paediatric patients compliance with implementation of this system in daily practice., Methods: The cross-sectional study included 499 records of patients aged 0-18 yr. Data from the insulin pump memory provided information on the number of D-W/S-W boluses during a 2-wk period, the insulin requirement (U/kg/d) and the percentage of basal insulin. The HbA1c value (%) and the patient's weight were determined during medical examinations. Mealtime dose of insulin in D-W/S-W bolus was calculated based on the amount of carbohydrate and fat/protein products., Results: The number of applied D-W/S-W boluses was 16.6 +/- 0.77/14 d (ranged 0-95), while 18.8% of patients did not program D-W/S-W boluses. The lowest HbA1c value was found in the group using two and/or more D-W/S-W boluses per day (p = 0.001) compared with the group administrating less than one D-W/S-W bolus/d. Patients with HbA1c level <7.5% had a statistically higher relevant number of D-W/S-W boluses, 19.55 (95% CI: 17.44-21.65) vs. 12.42 (95% CI: 10.22-14.61) (p < 0.001), while there was no correlation between the number of boluses and HbA1c in patients in the remission phase (<0.5 IU/kg/d) (r = 0.012, p = 0.930)., Conclusions: Patients using at least one D-W/S-W bolus per day achieved a recommended level of HbA1c. Paediatric patients with type 1 diabetes mellitus were found to be able to apply D-W/S-W boluses in daily self-treatment process based on food counting.
- Published
- 2009
- Full Text
- View/download PDF